Edland SD, Llibre-Guerra JJ. Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain. Neurology. 2023 Oct 3;101(14):593-594. Epub 2023 Aug 29 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Semorinemab